MICHELLE WARREN: Open Payments
NPI 1790259968 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 21 payments from 12 companies in 2025. Trend: 2023 $1,038 · 2024 $694 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $100 |
| Alkermes, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: INGREZZA, REXULTI, VRAYLAR, Auvelity, FANAPT, COBENFY, KEYTRUDA, ARISTADA.
Industry payments across UT — which companies pay providers there.
